AG
KRTX

Advisor Group’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Advisor Group’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1K Buy
+12
New +$526 ﹤0.01% 5229

Other funds holding KRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Advisor Group's KRTX Position: Q4 2019 in Review

Advisor Group opened a new position in Karuna Therapeutics, Inc. Common Stock (KRTX) in Q4 2019: 12 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #5229 among its holdings.

85 funds tracked by Wall St. Rank hold KRTX as of Q4 2019.

  • Advisor Group held 12 shares of Karuna Therapeutics, Inc. Common Stock worth $1K as of Q4 2019.
  • Karuna Therapeutics, Inc. Common Stock was a new Advisor Group position in Q4 2019.
  • Karuna Therapeutics, Inc. Common Stock made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5229 holding.
  • 85 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.